FA
HOLX

Friess Associates’s Hologic HOLX Stock Holding History

Friess Associates’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15,672
Closed -$1.2M – 63
2022
Q1 		$1.2M Buy
+15,672
New +$1.13M 0.64% 56
2017
Q3 		– Sell
-384,000
Closed -$17.4M – 113
2017
Q2 		$17.4M Buy
+384,000
New +$17M 1.58% 16

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Friess Associates's HOLX Position: Q2 2022 in Review

Friess Associates sold out of Hologic (HOLX) in Q2 2022, closing a stake of 15,672 shares — an estimated $1.2M sold.

Friess Associates first reported a position in HOLX in Q2 2017 and held it in 2 quarters. The position peaked at $17.4M in Q2 2017. 694 funds tracked by Wall St. Rank hold HOLX as of Q2 2022.

  • Friess Associates reported no remaining Hologic position as of Q2 2022 after selling out during the quarter.
  • Friess Associates sold 15,672 Hologic shares in Q2 2022, an estimated $1.2M.
  • Friess Associates first reported a position in Hologic in Q2 2017 and held it in 2 quarters.
  • Friess Associates's Hologic position peaked at $17.4M in Q2 2017.
  • 694 funds tracked by Wall St. Rank held Hologic as of Q2 2022.

Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.